$1.3 Billion is the total value of Slate Path Capital LP's 26 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 116.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOLD | Buy | BARRICK GOLD CORPORATION | $185,856,000 | +2.1% | 10,145,000 | +3.6% | 14.25% | +45.3% |
| MYL | New | MYLAN NV | $160,804,000 | – | 10,785,000 | +100.0% | 12.33% | – |
| MOS | Buy | MOSAIC CO NEW | $70,817,000 | -46.5% | 6,545,000 | +6.9% | 5.43% | -23.9% |
| PAAS | Buy | PAN AMERN SILVER CORP | $63,482,000 | -25.6% | 4,430,000 | +23.1% | 4.87% | +6.0% |
| FCX | Buy | FREEPORT-MCMORAN INCcl b | $50,828,000 | -44.5% | 7,530,000 | +7.9% | 3.90% | -21.0% |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $13,521,000 | – | 1,340,000 | +100.0% | 1.04% | – |
| ENDP | Buy | ENDO INTL PLC | $12,506,000 | +661.6% | 3,380,000 | +865.7% | 0.96% | +989.8% |
| LX | Buy | LEXINFINTECH HLDGS LTDadr | $3,903,000 | +24.9% | 440,000 | +95.6% | 0.30% | +78.0% |
| W | New | WAYFAIR INCcl a | $3,741,000 | – | 70,000 | +100.0% | 0.29% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $3,574,000 | – | 420,000 | +100.0% | 0.27% | – |
| CYCN | New | CYCLERION THERAPEUTICS INC | $3,170,000 | – | 1,196,063 | +100.0% | 0.24% | – |
| RIG | New | TRANSOCEAN LTD | $545,000 | – | 470,000 | +100.0% | 0.04% | – |
| ARCH | New | ARCH COAL INCcl a | $520,000 | – | 18,000 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
| SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.